Boc-L-亮氨腈 | 115654-59-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: Boc-L-亮氨腈
• 中文别名: N-叔丁氧羰基-L-亮氨腈；N-[(1S)-1-氰基-3-甲基丁基]-氨基甲酸-1,1-二甲基乙酯；N-[(1S)-1-氰基-3-甲基丁基]氨基甲酸叔丁酯
• 英文名称: (S)-tert-butyl 1-cyano-3-methylbutylcarbamate
• 英文别名: N-tert-butyloxycarbonyl leucine nitrile；(S)-N-tert-butyloxycarbonyl-1-cyano-3-methyl-butylamine；(S)-tert-Butyl (1-cyano-3-methylbutyl)carbamate；tert-butyl N-[(1S)-1-cyano-3-methylbutyl]carbamate
• CAS: 115654-59-6
• 化学式: C₁₁H₂₀N₂O₂
• 分子量: 212.292
• InChiKey: ZTELWEIFTFYNJS-VIFPVBQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  62.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Boc-L-亮氨腈 在 lithium aluminium tetrahydride 、 水 、 氯化铵 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 生成 氨甲酸,[1-(氨基甲基)-3-甲基丁基]-,1,1-二甲基乙基酯,(S)-
  参考文献：
  名称：

  Isoselenocyanates derived from Boc/Z-amino acids: synthesis, isolation, characterization, and application to the efficient synthesis of unsymmetrical selenoureas and selenoureidopeptidomimetics

  摘要：

  Isoselenocyanates derived from Boc/Z-amino acids are prepared by the reaction of the corresponding isonitriles with selenium powder in presence of triethylamine at reflux. The utility of these new classes of isoselenocyanates in the preparation of selenoureidodipeptidomimetics possessing both amino as well as carboxy termini has been accomplished. The H-1 NMR analysis confirmed that the protocol involving the conversion of isonitriles to isoselenocyanates and their use as coupling agents in assembling selenour-eido derivatives is free from racemization. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2010.06.082
• 作为产物：
  描述：

  ethoxycarbonyl (2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate 在 氨 、 三氟乙酸酐 作用下， 以 吡啶 、 水 为溶剂， 反应 5.5h， 生成 Boc-L-亮氨腈
  参考文献：
  名称：

  Boeijen, Astrid; Liskamp, Rob M. J., European Journal of Organic Chemistry, 1999, # 9, p. 2127 - 2135

  摘要：

  DOI：

文献信息

• Synthesis of Boc-Amino Tetrazoles Derived from α-Amino Acids
  作者：Vommina V. Sureshbabu、Shankar A. Naik、G. Nagendra

  DOI：10.1080/00397910802374133

  日期：2009.1.13

  Abstract A simple route for the synthesis of Boc-protected tetrazole analogs of amino acids starting from N α-Boc amino acids has been described. The [2 + 3] cycloaddition of Boc-α-amino nitrile and sodium azide in the presence of a catalytic amount of zinc bromide yielded the desired tetrazoles in good yields and purity. All the compounds obtained have been characterized by 1H and 13C-NMR and mass

  摘要 描述了从 N α-Boc 氨基酸开始合成 Boc 保护的四唑氨基酸类似物的简单途径。在催化量的溴化锌存在下，Boc-α-氨基腈和叠氮化钠的[2+3]环加成以良好的产率和纯度得到所需的四唑。获得的所有化合物均已通过 1H 和 13C-NMR 和质谱研究进行表征。
• Design, synthesis and cytotoxic evaluation of a library of oxadiazole-containing hybrids
  作者：Cristián M. Camacho、Marianela G. Pizzio、David L. Roces、Dora B. Boggián、Ernesto G. Mata、Yanina Bellizzi、Elizabeth Barrionuevo、Viviana C. Blank、Leonor P. Roguin

  DOI：10.1039/d1ra05602f

  日期：——

  The development of hybrid compounds led to the discovery of new pharmacologically active agents for some of the most critical diseases, including cancer. Herein, we describe a new series of oxadiazole-containing structures designed by a molecular hybridization approach. Penicillin derivatives and amino acids were linked to amino acid and aromatic moieties through the formation of a 1,2,4-oxadiazole

  混合化合物的开发导致发现了一些最严重的疾病（包括癌症）的新药理活性剂。在此，我们描述了通过分子杂交方法设计的一系列新的含恶二唑结构。青霉素衍生物和氨基酸通过形成 1,2,4-恶二唑环与氨基酸和芳香部分相连。或者，氨基酸衍生的酰肼和活化的青霉酸之间的缩合导致一系列含 1,3,4-恶二唑青霉素的杂化物和非环化的二酰肼。从细胞毒性分析中可以看出，连接青霉素和脂肪族氨基酸的两种 1,2,4-恶二唑和一种 1,3,4-恶二唑表现出高度的细胞毒性选择性，对肿瘤细胞的效力是正常细胞的三到四倍。结果给出了一个非常有趣的观点，表明这些杂合化合物可以提供一种具有良好细胞毒性特征的新型抗肿瘤支架。
• Phase Transfer Catalyzed Enantioselective Strecker Reactions of α-Amido Sulfones with Cyanohydrins
  作者：Raquel P. Herrera、Valentina Sgarzani、Luca Bernardi、Francesco Fini、Daniel Pettersen、Alfredo Ricci

  DOI：10.1021/jo061566u

  日期：2006.12.1

  A study into the use of a chiral phase-transfer catalyst in conjunction with acetone cyanohydrin to effect the enantioselective formation of α-amino nitriles from α-amido sulfones is described. This novel catalytic asymmetric Strecker reaction is analyzed with regard to the possible mechanistic basis.

  描述了将手性相转移催化剂与丙酮氰醇结合使用以实现由α-酰胺基砜对映选择性形成α-氨基腈的研究。就可能的机理基础分析了这种新颖的催化不对称斯特雷克反应。
• Dipeptide nitriles
  申请人：Novartis AG

  公开号：US06353017B1

  公开（公告）日：2002-03-05

  N-terminal substituted dipeptide nitriles as defined are useful as inhibitors of cysteine cathepsins, e.g. cathepsins B, K, L and S, and can be used for the treatment of cysteine cathepsin dependent diseases and conditions, including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, tumors (especially tumor invasion and tumor metastasis), coronary disease, atherosclerosis (including atherosclerotic plaque rupture and destabilization). Particular dipeptide nitriles are compounds of formula I, or physiologically-acceptable and -cleavable esters or a salts thereof wherein: the symbols are as defined. In particular it has been found that by appropriate choice of groups R, R2, R3, R4, R5, X1, Y and L, the relative selectivity of the compounds as inhibitors of the various cysteine cathepsin types, e.g. cathepsins B, K, L and S may be altered, e.g. to obtain inhibitors which selectively inhibit a particular cathepsin type or combination of cathepsin types.

  N-末端取代二肽腈可作为半胱氨酸蛋白酶抑制剂，例如半胱氨酸蛋白酶B、K、L和S，并可用于治疗依赖于半胱氨酸蛋白酶的疾病和症状，包括炎症、类风湿关节炎、骨关节炎、骨质疏松、肿瘤（尤其是肿瘤侵袭和转移）、冠心病、动脉粥样硬化（包括动脉粥样硬化斑块破裂和不稳定）。特定的二肽腈化合物为公式I的化合物，或其生理上可接受和可裂解的酯或盐，其中：符号如定义。特别是发现通过适当选择基团R、R2、R3、R4、R5、X1、Y和L，可以改变化合物作为各种半胱氨酸蛋白酶类型抑制剂的相对选择性，例如半胱氨酸蛋白酶B、K、L和S，可改变，例如获得选择性抑制特定蛋白酶类型或蛋白酶类型组合的抑制剂。
• Dipeptide derivatives
  申请人：——

  公开号：US20040110806A1

  公开（公告）日：2004-06-10

  N-terminal substituted dipeptide nitriles as defined are useful as inhibitors of cysteine cathepsins, e.g. cathepsins B, K, L and S, and can be used for the treatment of cysteine cathepsin dependent diseases and conditions, including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, tumors (especially tumor invasion and tumor metastasis), coronary disease, atherosclerosis (including atherosclerotic plaque rupture and destabilization). Particular dipeptide nitriles are compounds of formula I, or physiologically-acceptable and -cleavable esters or a salts thereof 1 wherein: the symbols are as defined. In particular it has been found that by appropriate choice of groups R, R 2 , R 3 , R 4 , R 5 , X 1 , Y and L, the relative selectivity of the compounds as inhibitors of the various cysteine cathepsin types, e.g. cathepsins B, K, L and S may be altered, e.g. to obtain inhibitors which selectively inhibit a particular cathepsin type or combination of cathepsin types.

  N-末端取代的二肽硝基化合物可作为半胱氨酸蛋白酶的抑制剂，例如半胱氨酸蛋白酶B、K、L和S，并可用于治疗半胱氨酸蛋白酶依赖性疾病和病况，包括炎症、类风湿性关节炎、骨关节炎、骨质疏松症、肿瘤（尤其是肿瘤侵袭和转移）、冠心病、动脉粥样硬化（包括动脉粥样硬化斑块破裂和不稳定性）。特定的二肽硝基化合物是公式I的化合物，或其生理上可接受和可分解酯或其盐，其中：符号的定义如上所述。特别是，通过适当选择R、R2、R3、R4、R5、X1、Y和L基团，可以改变化合物作为不同半胱氨酸蛋白酶类型的抑制剂的相对选择性，例如获得选择性抑制特定半胱氨酸蛋白酶类型或半胱氨酸蛋白酶类型组合的抑制剂。